金ナノ粒子市場 – 2029年までの世界予測

Report Overview

The gold nanoparticles market is estimated at USD 0.50 billion in 2024 and is projected to reach USD 1.11 billion by 2029, at a CAGR of 16.3% from 2024 to 2029.

金ナノ粒子市場は2024年に5億米ドルに達すると推定され、2024年から2029年にかけて16.3%のCAGRで成長し、2029年には11億1,000万米ドルに達すると予測されています。

Due to its properties such as scalability, cost effectiveness, and precise control over particle size, shape and surface functionality. It is the most popular choice among manufacturers for producing gold nanoparticles. Unlike the other nanoparticles which are physically or biologically processed, chemically processed gold nanoparticles provides high yield production and consistent quality which make them ideal for commercial applications. Chemically processed gold nanoparticles are used in various end use industries such as pharmaceuticals & healthcare, electrical & electronics, chemicals, personal care & cosmetics.

スケーラビリティ、コスト効率、粒子サイズ、形状、表面機能の正確な制御などの特性により、金ナノ粒子の製造において製造業者の間で最も人気のある選択肢となっています。物理的または生物学的に処理された他のナノ粒子とは異なり、化学的に処理された金ナノ粒子は、高収率の生産と一貫した品質を提供するため、商業用途に最適です。化学的に処理された金ナノ粒子は、医薬品およびヘルスケア、電気および電子製品、化学薬品、パーソナルケアおよび化粧品など、さまざまな最終用途産業で使用されています。

‘‘In terms of value, proton therapy application accounted for the largest share of the overall gold nanoparticles market.’’

Proton therapy application is projected to be the highest market share holding application in the gold nanoparticles market. Proton therapy is one of the groundbreaking advancements in cancer radiotherapy. Despite its advancements proton therapy faces challenges in precision and efficacy, but recent research has highlighted the potential of gold nanoparticles to enhance proton therapy outcomes. Gold nanoparticles have high atomic number and favourable biological properties through which it acts as a radiosensitizers by amplifying generation of secondary electrons and reactive oxygen species upon proton irradiation. This enhances DNA damage in tumor cells while preserving healthy tissues. Thus gold nanoparticles act as a backbone for enhancing proton therapy.

“During the forecast period, the gold nanoparticles market in pharmaceuticals & healthcare industry is projected to have highest market share.”

During the forecast period from 2024 to 2029, the pharmaceuticals & healthcare industry is expected to have the highest market share in end-use industry in the gold nanoparticles market. The demand for gold nanoparticles is rising in pharmaceuticals & healthacre industry due to its superior performance characteristics, including biocompatibility, optical properties, surface properties and others. Top leading pharmaceutical manufactures such as Gilead Sciences, Inc., and GSK plc. have already adopted gold nanoparticles for vaccine development and kits. Pharmaceuticals & healthcare end use industry is tend to grow with high rate and which will increase the consumption of gold nanoparticles.

“During the forecast period, the gold nanoparticles market in Asia Pacific region is projected to be the fastest growing region.”

Asia Pacific is the fastest growing market for gold nanoparticles because of its strong demand from pharmaceuticals & healthcare, which is a driving factor for high-performance materials such as gold nanoparticles. The region is dominated by large pharmaceuticals manufacturers, Sun Pharmaceutical Industries Ltd., Sapien Biosciences, which have comprehensive use of gold nanoparticles in various applications. Asia Pacific region has major countries such as India, China which has highest population in the world, and which will tend to increase the demand for pharmaceuticals & healthcare needs. Second, Asia Pacific region is home to various gold nanoparticles manufacturers such as ARITECH CHEMAZONE PVT LTD., Oparin Biotech Pvt Ltd and others.

This study has been validated through primary interviews with industry experts globally. These primary sources have been divided into the following three categories:

• By Company Type- Tier 1- 60%, Tier 2- 20%, and Tier 3- 20%
• By Designation- C Level- 33%, Director Level- 33%, and Managers- 34%
• By Region- North America- 20%, Europe- 25%, Asia Pacific- 25%, Middle East & Africa- 15%, and Latin America- 15%

The report provides a comprehensive analysis of company profiles:

Prominent companies BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany),  Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US).

Research Coverage

This research report categorizes the gold nanoparticles market By Process (Physical, Chemical, and Biological), By Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis, and Other Applications), End-Use Industry (Pharmaceuticals & Healthcare, Electrical & Electronics, Chemicals, Personal Care & Cosmetics, and Other End-use Industries), Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America). The scope of the report includes detailed information about the major factors influencing the growth of the gold nanoparticles market, such as drivers, restraints, challenges, and opportunities. A thorough examination of the key industry players has been conducted in order to provide insights into their business overview, solutions, and services, key strategies, contracts, partnerships, and agreements. Product launches, mergers and acquisitions, and recent developments in the gold nanoparticles market are all covered. This report includes a competitive analysis of upcoming startups in the gold nanoparticles market ecosystem.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall gold nanoparticles market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing demand for gold nanoparticles in electrical & electronics end use industry, unique properties of gold nanoparticles), restraints (Toxicity concerns of gold nanoparticles, stringent regulations impacting market development), opportunities (Increasing in research & development efforts in nanotechnology applications, growing demand for gold nanoparticles in various end use industries), and challenges (High time consumption for certain synthesis methods, growing cost of gold as a raw material) influencing the growth of the gold nanoparticles market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and service launches in the gold nanoparticles market.

• Market Development: Comprehensive information about lucrative markets – the report analyses the gold nanoparticles market across varied regions.

• Market Diversification: Exhaustive information about services, untapped geographies, recent developments, and investments in the gold nanoparticles market

• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), among others in the gold nanoparticles market.

Table of Contents

1               INTRODUCTION              24

1.1           STUDY OBJECTIVES       24

1.2           MARKET DEFINITION   24

1.3           STUDY SCOPE   25

1.3.1        MARKETS COVERED AND REGIONAL SPREAD    25

1.3.2        INCLUSIONS AND EXCLUSIONS OF STUDY          26

1.3.3        YEARS CONSIDERED      27

1.3.4        CURRENCY CONSIDERED            27

1.3.5        UNIT CONSIDERED        27

1.4           STAKEHOLDERS               27

2               RESEARCH METHODOLOGY       28

2.1           RESEARCH DATA              28

2.1.1        SECONDARY DATA          29

2.1.1.1    List of major secondary sources         29

2.1.1.2    Key data from secondary sources       29

2.1.2        PRIMARY DATA 30

2.1.2.1    Key data from primary sources           30

2.1.2.2    Key industry insights           31

2.1.2.3    Breakdown of primary interviews      31

2.2           MARKET SIZE ESTIMATION         32

2.2.1        BOTTOM-UP APPROACH              32

2.2.2        TOP-DOWN APPROACH                32

2.3           DATA TRIANGULATION                33

2.4           RESEARCH ASSUMPTIONS           34

2.5           GROWTH RATE ASSUMPTIONS/FORECAST         34

2.5.1        SUPPLY SIDE     34

2.5.1.1    List of major companies      35

2.5.2        DEMAND SIDE  35

2.6           RISK ASSESSMENT           35

2.7           LIMITATION      35

3               EXECUTIVE SUMMARY  36

4               PREMIUM INSIGHTS       40

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN GOLD NANOPARTICLES MARKET          40

4.2           GOLD NANOPARTICLES MARKET, BY PROCESS 40

4.3           GOLD NANOPARTICLES MARKET, BY APPLICATION                 41

4.4           GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY           41

4.5           GOLD NANOPARTICLES MARKET, BY REGION   42

5               MARKET OVERVIEW       43

5.1           INTRODUCTION              43

5.2           MARKET DYNAMICS       43

5.2.1        DRIVERS               44

5.2.1.1    Rising adoption of gold nanoparticles in next-gen electronics: powering smartphones, tablets, touchscreens, and GPS technologies                 44

5.2.1.2    High demand for gold nanoparticles in pharmaceutical &

healthcare end-use industry                44

5.2.1.3    Unique properties of gold nanoparticles           46

5.2.1.4    Growing demand for oil-soluble gold nanoparticles       46

5.2.2        RESTRAINTS      46

5.2.2.1    Toxicity concerns of gold nanoparticles            46

5.2.2.2    Stringent regulations impacting market development    47

5.2.3        OPPORTUNITIES              48

5.2.3.1    Increase in research & development efforts in nanotechnology applications           48

5.2.3.2    Emerging applications in various end-use industries     48

5.2.4        CHALLENGES    49

5.2.4.1    High time consumption for certain synthesis methods  49

5.2.4.2    Growing price for gold as raw material             49

5.3           PORTER’S FIVE FORCES ANALYSIS           50

5.3.1        THREAT OF NEW ENTRANTS      50

5.3.2        THREAT OF SUBSTITUTES          51

5.3.3        BARGAINING POWER OF BUYERS             51

5.3.4        BARGAINING POWER OF SUPPLIERS       52

5.3.5        INTENSITY OF COMPETITIVE RIVALRY 52

5.4           KEY STAKEHOLDERS AND BUYING CRITERIA     53

5.4.1        KEY STAKEHOLDERS IN BUYING PROCESS           53

5.4.2        BUYING CRITERIA           53

5.5           MACROECONOMIC INDICATORS              55

5.5.1        GLOBAL GDP TRENDS  55

5.6           IMPACT OF GEN AI          56

5.7           VALUE CHAIN ANALYSIS               56

5.7.1        RAW MATERIAL SUPPLIERS (GOLD SOURCE & PRECURSORS)   57

5.7.2        MANUFACTURERS (SYNTHESIS & PROCESSING)                 57

5.7.3        SUPPLIERS/DISTRIBUTORS        57

5.7.4        END-USE INDUSTRIES   58

5.8           ECOSYSTEM ANALYSIS  58

5.9           CASE STUDY ANALYSIS 59

5.9.1        ENHANCING CLINICAL EFFECTIVENESS OF GOLD NANOPARTICLES

IN MEDICAL APPLICATIONS       59

5.9.2        OPTIMIZING GOLD NANOPARTICLE SYNTHESIS USING DESIGN OF EXPERIMENTS (DOE)             60

5.10         REGULATORY LANDSCAPE         60

5.10.1      REGULATIONS  60

5.10.1.1  Europe   60

5.10.1.2  Asia Pacific            61

5.10.1.3  North America      62

5.10.2      STANDARDS      63

5.10.2.1  ISO 10993              63

5.10.2.2  ISO/TS 27687       63

5.10.2.3  ISO 13321              63

5.10.3      REGULATORY BODIES, GOVERNMENT BODIES, AND OTHER AGENCIES           63

5.11         TECHNOLOGY ANALYSIS             64

5.11.1      KEY TECHNOLOGIES     64

5.11.1.1  Colloidal synthesis and green synthesis methods            64

5.11.1.2  Plasmonic & optical sensing technologies        64

5.11.2      COMPLEMENTARY TECHNOLOGIES       64

5.11.2.1  Microfluidics & Lab-on-a-Chip Devices           64

5.11.3      ADJACENT TECHNOLOGIES       65

5.11.4      QUANTUM DOTS & NANOELECTRONICS              65

5.12         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            65

5.13         TRADE ANALYSIS             66

5.13.1      EXPORT SCENARIO (HS CODE 284310)    66

5.13.2      IMPORT SCENARIO (HS CODE 284310)    66

5.14         KEY CONFERENCES & EVENTS IN 2024–2025          67

5.15         PRICING ANALYSIS          68

5.15.1      AVERAGE SELLING PRICE TREND, BY REGION   68

5.15.2      AVERAGE SELLING PRICE TREND, BY END-USE INDUSTRY, 2022–2029      69

5.15.3      AVERAGE SELLING PRICE OF KEY PLAYERS, BY END-USE INDUSTRY, 2023                 70

5.16         INVESTMENT AND FUNDING SCENARIO               70

5.17         PATENT ANALYSIS          71

5.17.1      APPROACH         71

5.17.2      DOCUMENT TYPES         71

5.17.3      PUBLICATION TRENDS, 2013–2023            72

5.17.4      INSIGHTS            72

5.17.5      LEGAL STATUS OF PATENTS      72

5.17.6      JURISDICTION ANALYSIS              73

5.17.7      TOP COMPANIES/APPLICANTS 73

5.17.8      TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS                 74

6               GOLD NANOPARTICLES MARKET, BY PROCESS 75

6.1           INTRODUCTION              76

6.2           PHYSICAL            77

6.2.1        PRODUCTION OF HIGHLY UNIFORM NANOPARTICLES TO DRIVE DEMAND        77

6.3           CHEMICAL          78

6.3.1        WIDE USE IN VARIOUS APPLICATIONS TO DRIVE DEMAND             78

6.4           BIOLOGICAL      78

6.4.1        APPLICATIONS IN BIOMEDICINE, ENVIRONMENTAL SCIENCE, AND

CATALYSIS TO DRIVE DEMAND                78

7               GOLD NANOPARTICLES MARKET, BY APPLICATION                 79

7.1           INTRODUCTION              80

7.2           IMAGING             82

7.2.1        INCREASING DEMAND FOR IMAGING APPLICATIONS                 82

7.3           TARGETED DRUG DELIVERY      83

7.3.1        INCREASING NEED FOR PRECISION DRUG DELIVERY WITH MINIMAL

SIDE EFFECTS TO DRIVE DEMAND          83

7.4           PROTON THERAPY         84

7.4.1        GROWING DEMAND FOR HIGHLY EFFECTIVE AND SAFER CANCER TREATMENTS TO FUEL INTEREST IN GNP-ASSISTED PROTON THERAPY    84

7.5           IN-VITRO ASSAYS             84

7.5.1        INCREASING DEMAND FOR RAPID, POINT-OF-CARE DIAGNOSTICS,

AND HIGH-THROUGHPUT SCREENING METHODS TO DRIVE MARKET               84

7.6           SENSORS              85

7.6.1        HIGH-PERFORMANCE, PORTABLE, AND REAL-TIME SENSING

TECHNOLOGIES TO DRIVE DEMAND     85

7.7           PROBES                85

7.7.1        RISING NEED FOR HIGHLY SENSITIVE AND MULTIPLEXED DETECTION PLATFORMS TO DRIVE DEMAND                 85

7.8           CATALYSIS          86

7.8.1        HIGH STABILITY, RECYCLABILITY, AND ABILITY TO OPERATE UNDER MILD REACTION CONDITIONS TO DRIVE DEMAND FOR GOLD NANOPARTICLES

IN CATALYSIS APPLICATION      86

7.9           OTHER APPLICATIONS 87

7.9.1        GROWING NEED FOR PRECISION MEDICINE, ADVANCED BIOSENSORS,

AND SUSTAINABLE SOLUTIONS TO DRIVE DEMAND      87

8               GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY           88

8.1           INTRODUCTION              89

8.2           PHARMACEUTICALS & HEALTHCARE     91

8.2.1        TARGETED DRUG DELIVERY SYSTEM AND DIAGNOSTIC APPLICATIONS

TO INCREASE DEMAND FOR GOLD NANOPARTICLES    91

8.3           ELECTRICAL & ELECTRONICS    91

8.3.1        CONDUCTIVITY AND FLEXIBILITY TO DRIVE DEMAND IN ELECTRICAL

AND ELECTRONICS INDUSTRIES              91

8.4           CHEMICALS        92

8.4.1        CATALYSIS AND GREEN CHEMISTRY APPLICATION TO DRIVE DEMAND               92

8.5           PERSONAL CARE & COSMETICS 92

8.5.1       ANTIBACTERIAL, ANTIFUNGAL, ANTI-INFLAMMATORY, AND REGENERATIVE PROPERTIES OF GOLD NANOPARTICLES TO DRIVE DEMAND        92

8.6           OTHER END-USE INDUSTRIES   93

9               GOLD NANOPARTICLES MARKET, BY REGION   94

9.1           INTRODUCTION              95

9.2           NORTH AMERICA             97

9.2.1        US           102

9.2.1.1    Growing healthcare and cosmetics industries to boost market                 102

9.2.2        CANADA               104

9.2.2.1    Demand from growing chemical, healthcare, and cosmetics industries to propel market 104

9.2.3        MEXICO                106

9.2.3.1    Healthcare industry to drive market  106

9.3           EUROPE               108

9.3.1        GERMANY           114

9.3.1.1    Rising investment in healthcare sector to drive demand for

gold nanoparticles                 114

9.3.2        FRANCE                115

9.3.2.1    Increasing utilization of gold nanoparticles in various

end-use industries to boost market   115

9.3.3        SPAIN    117

9.3.3.1    Opportunities in pharmaceutical & healthcare industry to

fuel demand           117

9.3.4        UK          119

9.3.4.1    Demand for gold nanoparticles in healthcare industry to

propel market        119

9.3.5        ITALY    120

9.3.5.1    Chemicals, pharmaceuticals, and food & beverage industries

to boost demand   120

9.3.6        REST OF EUROPE             122

9.4           ASIA PACIFIC     124

9.4.1        CHINA  129

9.4.1.1    High requirement of gold nanoparticles in various end-use

industries to drive demand 129

9.4.2        JAPAN   131

9.4.2.1    Gold nanoparticles’ requirement in various end-use industries

to drive market      131

9.4.3        INDIA    133

9.4.3.1    Growth of pharmaceutical industry to increase demand                 133

9.4.4        SOUTH KOREA  134

9.4.4.1    Strategic focus on healthcare industry to drive growth  134

9.4.5        REST OF ASIA PACIFIC   136

9.5           MIDDLE EAST & AFRICA                138

9.5.1        GCC COUNTRIES              144

9.5.1.1    UAE        145

9.5.1.1.1 Significantly expanding healthcare sector to propel

market growth       145

9.5.1.2    Saudi Arabia          147

9.5.1.2.1 Improvised healthcare sector to drive demand                 147

9.5.1.3    Rest of GCC countries         148

9.5.2        TÜRKIYE              150

9.5.2.1    Advancement in nanotechnology to increase demand   150

9.5.3        SOUTH AFRICA 152

9.5.3.1    Diversified economy to drive growth                 152

9.5.4        REST OF MIDDLE EAST & AFRICA             153

9.6           SOUTH AMERICA             155

9.6.1        BRAZIL 160

9.6.1.1    Increasing investments in electronic industry to drive growth                 160

9.6.2        ARGENTINA       162

9.6.2.1    Growing pharmaceutical sector to drive market              162

9.6.3        REST OF SOUTH AMERICA           164

10            COMPETITIVE LANDSCAPE         166

10.1         OVERVIEW          166

10.2         KEY PLAYER STRATEGIES             166

10.3         REVENUE ANALYSIS, 2021–2023  167

10.4         MARKET SHARE ANALYSIS           168

10.5         COMPANY VALUATION AND FINANCIAL METRICS                 171

10.6         BRAND/PRODUCT COMPARISON ANALYSIS        172

10.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 173

10.7.1      STARS   173

10.7.2      EMERGING LEADERS     173

10.7.3      PERVASIVE PLAYERS      174

10.7.4      PARTICIPANTS 174

10.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         175

10.7.5.1  Company footprint               175

10.7.5.2  Region footprint   176

10.7.5.3  Process footprint  177

10.7.5.4  Applications          178

10.7.5.5  End-use industry footprint 179

10.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        180

10.8.1      PROGRESSIVE COMPANIES         180

10.8.2      RESPONSIVE COMPANIES            180

10.8.3      DYNAMIC COMPANIES  180

10.8.4      STARTING BLOCKS         180

10.8.5      COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2023        182

10.8.5.1  Detailed list of key startups/SMEs    182

10.8.5.2  Competitive benchmarking of key startups/SMEs          183

10.9         COMPETITIVE SCENARIO AND TRENDS                184

10.9.1      PRODUCT LAUNCHES   184

10.9.2      EXPANSIONS     184

10.9.3      DEALS  185

11            COMPANY PROFILES      186

11.1         KEY PLAYERS     186

11.1.1      BBI SOLUTIONS                186

11.1.1.1  Business overview 186

11.1.1.2  Products/Solutions/Services offered 186

11.1.1.3  Recent developments           187

11.1.1.3.1                Deals      187

11.1.1.4  MnM view              188

11.1.1.4.1                Right to win           188

11.1.1.4.2                Strategic choices   188

11.1.1.4.3                Weaknesses and competitive threats 188

11.1.2      CYTODIAGNOSTICS INC               189

11.1.2.1  Business overview 189

11.1.2.2  Products/Solutions/Services offered 189

11.1.2.3  MnM view              191

11.1.2.3.1                Right to win           191

11.1.2.3.2                Strategic choices   191

11.1.2.3.3                Weaknesses and competitive threats 192

11.1.3      FORTIS LIFE SCIENCES, LLC.       193

11.1.3.1  Business overview 193

11.1.3.2  Products/Solutions/Services offered 193

11.1.3.3  Recent developments           195

11.1.3.3.1                Deals      195

11.1.3.4  MnM view              196

11.1.3.4.1                Right to win           196

11.1.3.4.2                Strategic choices   196

11.1.3.4.3                Weaknesses and competitive threats 196

11.1.4      MELIORUM TECHNOLOGIES, INC             197

11.1.4.1  Business overview 197

11.1.4.2  Products/Solutions/Services offered 197

11.1.4.3  MnM view              198

11.1.5      JOHNSON MATTHEY      199

11.1.5.1  Business overview 199

11.1.5.2  Products/Solutions/Services offered 200

11.1.5.3  MnM view              201

11.1.6      TANAKA PRECIOUS METAL GROUP CO.                 202

11.1.6.1  Business overview 202

11.1.6.2  Products/Solutions/Services offered 203

11.1.6.3  Recent developments           203

11.1.6.3.1                Product Launch    203

11.1.6.4  MnM view              204

11.1.6.4.1                Right to win           204

11.1.6.4.2                Strategic choices   204

11.1.6.4.3                Weaknesses and competitive threats 204

11.1.7      SIGMA ALDRICH (MERCK KGAA)               205

11.1.7.1  Business overview 205

11.1.7.2  Products/Solutions/Services offered 206

11.1.7.3  Recent developments           207

11.1.7.3.1                Expansions             207

11.1.7.4  MnM view              207

11.1.7.4.1                Right to win           207

11.1.7.4.2                Strategic choices   208

11.1.7.4.3                Weaknesses and competitive threats 208

11.1.8      NANOPARTZ INC.            209

11.1.8.1  Business overview 209

11.1.8.2  Products/Solutions/Services offered 209

11.1.8.3  MnM view              210

11.1.9      CD BIOPARTICLES           211

11.1.9.1  Business overview 211

11.1.9.2  Products/Solutions/Services offered 211

11.1.9.3  MnM view              213

11.1.10   NANO LABS        214

11.1.10.1                 Business overview 214

11.1.10.2                 Products/Solutions/Services offered 214

11.1.10.3                 MnM view              214

11.1.11   NANOCS INC      215

11.1.11.1                 Business overview 215

11.1.11.2                 Products/Solutions/Services offered 215

11.1.11.3                 MnM view              216

11.2         OTHER PLAYERS              217

11.2.1      NANOHYBRIDS 217

11.2.2      FORTIS LIFE SCIENCES  218

11.2.3      SONA NANOTECH           219

11.2.4      SISCO RESEARCH LABORATORIES PVT, LTD.      220

11.2.5      NANOPROBES, INC          221

11.2.6      AMERICAN ELEMENTS  222

11.2.7      TORSKAL             223

11.2.8      ABCAM LIMITED              224

11.2.9      PARTICULAR GMBH       225

11.2.10   DONGGUAN SAT NANO TECHNOLOGY MATERIAL CO., LTD        226

11.2.11   NANO FLOW      227

11.2.12   STREM CATALOG             228

11.2.13   NANORH              229

11.2.14   SKYSPRING NANOMATERIALS, INC          230

11.2.15   AURION                231

11.2.16   NNCRYSTAL US CORPORATION                232

12            APPENDIX           233

12.1         DISCUSSION GUIDE        233

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                236

12.3         CUSTOMIZATION OPTIONS        238

12.4         RELATED REPORTS         238

12.5         AUTHOR DETAILS           239

LIST OF TABLES

TABLE 1                GOLD NANOPARTICLES MARKET: INCLUSIONS AND EXCLUSIONS           26

TABLE 2                GOLD NANOPARTICLES MARKET: PORTER’S FIVE FORCES      52

TABLE 3                INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY

END-USE INDUSTRIES (%)           53

TABLE 4                KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES       54

TABLE 5                PROJECTED REAL GDP GROWTH (ANNUAL PERCENT CHANGE) OF

KEY COUNTRIES, 2021–2029          55

TABLE 6                PHARMACEUTICALS SALES OF KEY REGIONS (PERCENTAGE) 2021       56

TABLE 7                GOLD NANOPARTICLES MARKET: ROLE OF PLAYERS IN ECOSYSTEM              58

TABLE 8                GOLD NANOPARTICLES MARKET: LIST OF SUPPLIERS FACING REGULATORY CHALLENGES AND APPROVALS        62

TABLE 9                GOLD NANOPARTICLES MARKET: LIST OF REGULATORY BODIES,

GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 63

TABLE 10              GOLD NANOPARTICLES MARKET: DETAILED LIST OF CONFERENCES

& EVENTS, 2024–2025       67

TABLE 11              INDICATIVE AVERAGE SELLING PRICE OF GOLD NANOPARTICLES,

BY REGION (USD/KG)    68

TABLE 12              INDICATIVE AVERAGE SELLING PRICE OF GOLD NANOPARTICLES,

BY END USE INDUSTRY (USD/KG)            69

TABLE 13              TOTAL PATENT COUNT               71

TABLE 14              PATENTS BY MERCK KGAA          74

TABLE 15              TOP 10 PATENT OWNERS IN LAST 10 YEARS                 74

TABLE 16              GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (USD MILLION)            76

TABLE 17              GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (USD MILLION)            77

TABLE 18              GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG)  77

TABLE 19              GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG)  77

TABLE 20              GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)              81

TABLE 21              GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)              81

TABLE 22              GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG)   81

TABLE 23              GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG)   82

TABLE 24              GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES,

2021–2023 (USD MILLION)            89

TABLE 25              GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES,

2024–2029 (USD MILLION)            90

TABLE 26              GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES, 2021–2023 (KG)       90

TABLE 27              GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRIES, 2024–2029 (KG)       90

TABLE 28              GOLD NANOPARTICLES MARKET, BY REGION, 2021–2023 (USD MILLION)            95

TABLE 29              GOLD NANOPARTICLES MARKET, BY REGION, 2024–2029 (USD MILLION)            96

TABLE 30              GOLD NANOPARTICLES MARKET, BY REGION, 2021–2023 (KG)  96

TABLE 31              GOLD NANOPARTICLES MARKET, BY REGION, 2024–2029 (KG)  96

TABLE 32              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            98

TABLE 33              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            98

TABLE 34              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2021–2023 (KG)  98

TABLE 35              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2024–2029 (KG)  98

TABLE 36              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2021–2023 (USD MILLION)            99

TABLE 37              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2024–2029 (USD MILLION)            99

TABLE 38              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2021–2023 (KG)  99

TABLE 39              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2024–2029 (KG)  99

TABLE 40              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            100

TABLE 41              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (USD MILLION)            100

TABLE 42              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (KG)  100

TABLE 43              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (KG)  101

TABLE 44              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            101

TABLE 45              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            101

TABLE 46              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  102

TABLE 47              NORTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  102

TABLE 48              US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            103

TABLE 49              US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            103

TABLE 50              US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 103

TABLE 51              US: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 104

TABLE 52              CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            105

TABLE 53              CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            105

TABLE 54              CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  105

TABLE 55              CANADA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  106

TABLE 56              MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            106

TABLE 57              MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            107

TABLE 58              MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  107

TABLE 59              MEXICO: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  107

TABLE 60              EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            109

TABLE 61              EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            109

TABLE 62              EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG)           109

TABLE 63              EUROPE: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG)           110

TABLE 64              EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS,

2021–2023 (USD MILLION)            110

TABLE 65              EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS,

2024–2029 (USD MILLION)            110

TABLE 66              EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG)              110

TABLE 67              EUROPE: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG)              111

TABLE 68              EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            111

TABLE 69              EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (USD MILLION)            111

TABLE 70              EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG)   112

TABLE 71              EUROPE: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG)   112

TABLE 72              EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            112

TABLE 73              EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            113

TABLE 74              EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  113

TABLE 75              EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  113

TABLE 76              GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            114

TABLE 77              GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            114

TABLE 78              GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  115

TABLE 79              GERMANY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  115

TABLE 80              FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            116

TABLE 81              FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            116

TABLE 82              FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  116

TABLE 83              FRANCE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  117

TABLE 84              SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            117

TABLE 85              SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            118

TABLE 86              SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       118

TABLE 87              SPAIN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       118

TABLE 88              UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            119

TABLE 89              UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            119

TABLE 90              UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 120

TABLE 91              UK: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 120

TABLE 92              ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            121

TABLE 93              ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            121

TABLE 94              ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       121

TABLE 95              ITALY: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       122

TABLE 96              REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)                 122

TABLE 97              REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)                 123

TABLE 98              REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)             123

TABLE 99              REST OF EUROPE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)             123

TABLE 100            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            124

TABLE 101            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            125

TABLE 102            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG)     125

TABLE 103            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG)     125

TABLE 104            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS,

2021–2023 (USD MILLION)            125

TABLE 105            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS,

2024–2029 (USD MILLION)            126

TABLE 106            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG)       126

TABLE 107            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG)       126

TABLE 108            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            126

TABLE 109            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (USD MILLION)            127

TABLE 110            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2021–2023 (KG)             127

TABLE 111            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY APPLICATION, 2024–2029 (KG)             128

TABLE 112            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            128

TABLE 113            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            128

TABLE 114            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  129

TABLE 115            ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  129

TABLE 116            CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            130

TABLE 117            CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            130

TABLE 118            CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  130

TABLE 119            CHINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       131

TABLE 120            JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            131

TABLE 121            JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            132

TABLE 122            JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       132

TABLE 123            JAPAN: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       132

TABLE 124            INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            133

TABLE 125            INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            133

TABLE 126            INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       134

TABLE 127            INDIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       134

TABLE 128            SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            135

TABLE 129            SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            135

TABLE 130            SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  135

TABLE 131            SOUTH KOREA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  136

TABLE 132            REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)                 136

TABLE 133            REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)                 137

TABLE 134            REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)             137

TABLE 135            REST OF ASIA PACIFIC: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)             137

TABLE 136            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            138

TABLE 137            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            138

TABLE 138            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2021–2023 (KG)  139

TABLE 139            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2024–2029 (KG)  139

TABLE 140            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2021–2023 (USD MILLION)            139

TABLE 141            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2024–2029 (USD MILLION)            140

TABLE 142            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2021–2023 (KG)  140

TABLE 143            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2024–2029 (KG)  140

TABLE 144            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            141

TABLE 145            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (USD MILLION)            141

TABLE 146            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (KG)  142

TABLE 147            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (KG)  142

TABLE 148            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 142

TABLE 149            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 143

TABLE 150            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       143

TABLE 151            MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       143

TABLE 152            GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            144

TABLE 153            GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            144

TABLE 154            GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  144

TABLE 155            GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  145

TABLE 156            UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            145

TABLE 157            UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            146

TABLE 158            UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG) 146

TABLE 159            UAE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG) 146

TABLE 160            SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            147

TABLE 161            SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            147

TABLE 162            SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  148

TABLE 163            SAUDI ARABIA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  148

TABLE 164            REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 149

TABLE 165            REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 149

TABLE 166            REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       149

TABLE 167            REST OF GCC COUNTRIES: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       150

TABLE 168            TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            150

TABLE 169            TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            151

TABLE 170            TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  151

TABLE 171            TÜRKIYE: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  151

TABLE 172            SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            152

TABLE 173            SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            152

TABLE 174            SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  153

TABLE 175            SOUTH AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  153

TABLE 176            REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 154

TABLE 177            REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 154

TABLE 178            REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       154

TABLE 179            REST OF MIDDLE EAST & AFRICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       155

TABLE 180            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            155

TABLE 181            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY,

2024–2029 (USD MILLION)            155

TABLE 182            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2021–2023 (KG) 156

TABLE 183            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY COUNTRY, 2024–2029 (KG) 156

TABLE 184            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2021–2023 (USD MILLION)            156

TABLE 185            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS,

2024–2029 (USD MILLION)            156

TABLE 186            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2021–2023 (KG)   157

TABLE 187            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY PROCESS, 2024–2029 (KG)   157

TABLE 188            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            157

TABLE 189            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (USD MILLION)            158

TABLE 190            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2021–2023 (KG)  158

TABLE 191            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY APPLICATION,

2024–2029 (KG)  159

TABLE 192            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            159

TABLE 193            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            159

TABLE 194            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  160

TABLE 195            SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  160

TABLE 196            BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            161

TABLE 197            BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            161

TABLE 198            BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  161

TABLE 199            BRAZIL: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  162

TABLE 200            ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (USD MILLION)            162

TABLE 201            ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (USD MILLION)            163

TABLE 202            ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2021–2023 (KG)  163

TABLE 203            ARGENTINA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY,

2024–2029 (KG)  163

TABLE 204            REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION) 164

TABLE 205            REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION) 165

TABLE 206            REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2021–2023 (KG)       165

TABLE 207            REST OF SOUTH AMERICA: GOLD NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2024–2029 (KG)       165

TABLE 208            GOLD NANOPARTICLES MARKET: DEGREE OF COMPETITION 169

TABLE 209            GOLD NANOPARTICLES MARKET: REGIONAL FOOTPRINT       176

TABLE 210            GOLD NANOPARTICLES MARKET: PROCESS FOOTPRINT       177

TABLE 211            GOLD NANOPARTICLES MARKET: APPLICATION FOOTPRINT         178

TABLE 212            GOLD NANOPARTICLES MARKET: END-USE INDUSTRY FOOTPRINT 179

TABLE 213            GOLD NANOPARTICLES: KEY STARTUPS/SMES                 182

TABLE 214            GOLD NANOPARTICLES MARKET: COMPETITIVE BENCHMARKING

OF STARTUPS/SMES       183

TABLE 215            GOLD NANOPARTICLES MARKET: PRODUCT LAUNCHES,

JANUARY 2020–APRIL 2024            184

TABLE 216            GOLD NANOPARTICLES MARKET: EXPANSIONS, JANUARY 2020–APRIL 2024            184

TABLE 217            GOLD NANOPARTICLES MARKET: DEALS, JANUARY 2020–APRIL 2024            185

TABLE 218            BBI SOLUTIONS: COMPANY OVERVIEW 186

TABLE 219            BBI SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED    186

TABLE 220            BBI SOLUTIONS: DEALS, JANUARY 2019–NOVEMBER 2024               187

TABLE 221            CYTODIAGNOSTICS INC: COMPANY OVERVIEW                 189

TABLE 222            CYTODIAGNOSTICS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    189

TABLE 223            FORTIS LIFE SCIENCES, LLC.: COMPANY OVERVIEW          193

TABLE 224            FORTIS LIFE SCIENCES, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    193

TABLE 225            FORTIS LIFE SCIENCES, LLC.: DEALS, JANUARY 2019–NOVEMBER 2024    195

TABLE 226            MELIORUM TECHNOLOGIES, INC: COMPANY OVERVIEW          197

TABLE 227            MELIORUM TECHNOLOGIES, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    197

TABLE 228            JOHNSON MATTHEY: COMPANY OVERVIEW                 199

TABLE 229            JOHNSON MATTHEY: PRODUCTS/SOLUTIONS/SERVICES OFFERED    200

TABLE 230            TANAKA PRECIOUS METAL GROUP CO.: COMPANY OVERVIEW   202

TABLE 231            TANAKA PRECIOUS METAL GROUP CO.: PRODUCTS/SOLUTIONS/

SERVICES OFFERED        203

TABLE 232            TANAKA PRECIOUS METAL GROUP CO.: PRODUCT LAUNCHES,

JANUARY 2019–NOVEMBER 2024                 203

TABLE 233            SIGMA ALDRICH: COMPANY OVERVIEW                 205

TABLE 234            SIGMA ALDRICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED    206

TABLE 235            SIGMA ALDRICH: EXPANSIONS, JANUARY 2019–NOVEMBER 2024               207

TABLE 236            NANOPARTZ INC.: COMPANY OVERVIEW                 209

TABLE 237            NANOPARTZ INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    209

TABLE 238            CD BIOPARTICLES: COMPANY OVERVIEW                 211

TABLE 239            CD BIOPARTICLES: PRODUCTS/SOLUTIONS/SERVICES OFFERED    211

TABLE 240            NANO LABS: COMPANY OVERVIEW         214

TABLE 241            NANO LABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED             214

TABLE 242            NANOCS INC: COMPANY OVERVIEW       215

TABLE 243            NANOCS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    215

TABLE 244            NANOHYBRIDS: COMPANY OVERVIEW  217

TABLE 245            FORTIS LIFE SCIENCES: COMPANY OVERVIEW                 218

TABLE 246            SONA NANOTECH: COMPANY OVERVIEW                 219

TABLE 247            SISCO RESEARCH LABORATORIES PVT, LTD.: COMPANY OVERVIEW   220

TABLE 248            NANOPROBES, INC: COMPANY OVERVIEW                 221

TABLE 249            AMERICAN ELEMENTS: COMPANY OVERVIEW                 222

TABLE 250            TORSKAL: COMPANY OVERVIEW              223

TABLE 251            ABCAM LIMITED: COMPANY OVERVIEW                 224

TABLE 252            PARTICULAR GMBH: COMPANY OVERVIEW                 225

TABLE 253            DONGGUAN SAT NANO TECHNOLOGY MATERIAL CO., LTD: COMPANY OVERVIEW        226

TABLE 254            NANO FLOW: COMPANY OVERVIEW       227

TABLE 255            STREM CATALOG: COMPANY OVERVIEW                 228

TABLE 256            NANORH: COMPANY OVERVIEW               229

TABLE 257            SKYSPRING NANOMATERIALS, INC: COMPANY OVERVIEW          230

TABLE 258            AURION: COMPANY OVERVIEW 231

TABLE 259            NNCRYSTAL US CORPORATION: COMPANY OVERVIEW          232

LIST OF FIGURES

FIGURE 1              GOLD NANOPARTICLES MARKET SEGMENTATION              25

FIGURE 2              GOLD NANOPARTICLES MARKET: RESEARCH DESIGN                28

FIGURE 3              GOLD NANOPARTICLES MARKET: BOTTOM-UP APPROACH         32

FIGURE 4              GOLD NANOPARTICLES MARKET: TOP-DOWN APPROACH         32

FIGURE 5              GOLD NANOPARTICLES MARKET: DATA TRIANGULATION             33

FIGURE 6              CHEMICAL PROCESS TO DOMINATE MARKET DURING FORECAST PERIOD       36

FIGURE 7              PROTON THERAPY TO CAPTURE LARGEST MARKET SHARE DURING

FORECAST PERIOD         37

FIGURE 8              PHARMACEUTICALS & HEALTHCARE TO BE LARGEST END-USE

INDUSTRY DURING FORECAST PERIOD                38

FIGURE 9              ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD    38

FIGURE 10            ASIA PACIFIC TO BE FASTEST-GROWING GOLD NANOPARTICLES

MARKET DURING FORECAST PERIOD    40

FIGURE 11            CHEMICAL PROCESS TO BE LARGER PROCESS DURING FORECAST PERIOD       40

FIGURE 12            PROTON THERAPY TO CAPTURE LARGEST SHARE DURING FORECAST PERIOD        41

FIGURE 13            PHARMACEUTICAL & HEALTHCARE INDUSTRY TO LEAD MARKET

DURING FORECAST PERIOD       41

FIGURE 14            ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD       42

FIGURE 15            DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

IN GOLD NANOPARTICLES MARKET       43

FIGURE 16            GOLD NANOPARTICLES MARKET: PORTER’S FIVE FORCES ANALYSIS 50

FIGURE 17            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF KEY

END-USE INDUSTRIES   53

FIGURE 18            KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES       54

FIGURE 19            OVERVIEW OF GOLD NANOPARTICLES VALUE CHAIN  57

FIGURE 20            GOLD NANOPARTICLES MARKET: ECOSYSTEM                 58

FIGURE 21            GOLD NANOPARTICLES MARKET: TRENDS/DISRUPTIONS

IMPACTING CUSTOMER BUSINESS          65

FIGURE 22            COUNTRY-WISE EXPORT TRADE VALUE FOR HS CODE 284310 (USD THOUSAND)                66

FIGURE 23            COUNTRY-WISE IMPORT TRADE VALUE FOR HS CODE 284310 (USD THOUSAND)                67

FIGURE 24           AVERAGE SELLING PRICE, BY REGION (USD/KG), 2022–2029              68

FIGURE 25            AVERAGE SELLING PRICE TREND, BY END-USE INDUSTRY (USD/KG), 2022–2029                 69

FIGURE 26            AVERAGE SELLING PRICE OF KEY PLAYERS, BY END-USE

INDUSTRY (USD/KG), 2023           70

FIGURE 27            INVESTMENT AND FUNDING SCENARIO                 70

FIGURE 28            TOTAL NUMBER OF PATENTS   71

FIGURE 29            NUMBER OF PATENTS YEAR-WISE FROM 2013–2023        72

FIGURE 30            PATENT ANALYSIS, BY LEGAL STATUS  72

FIGURE 31            TOP JURISDICTION, BY DOCUMENT       73

FIGURE 32            TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS               73

FIGURE 33            CHEMICAL PROCESS TO ACCOUNT FOR LARGEST MARKET SHARE            76

FIGURE 34            PROTON THERAPY APPLICATION TO ACCOUNT FOR LARGEST MARKET SHARE            80

FIGURE 35            ELECTRICAL & ELECTRONICS TO REGISTER HIGHEST CAGR

DURING FORECAST PERIOD       89

FIGURE 36            INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD         95

FIGURE 37            NORTH AMERICA: GOLD NANOPARTICLES MARKET SNAPSHOT       97

FIGURE 39            ASIA PACIFIC: GOLD NANOPARTICLES MARKET SNAPSHOT          124

FIGURE 40            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GOLD

NANOPARTICLES MARKET BETWEEN 2020 AND 2024       167

FIGURE 41            REVENUE ANALYSIS OF KEY COMPANIES IN GOLD NANOPARTICLES

MARKET, 2019–2023          168

FIGURE 42            SHARES OF TOP FIVE COMPANIES IN GOLD NANOPARTICLES MARKET, 2023                168

FIGURE 43            COMPANY VALUATION OF KEY COMPANIES IN GOLD

NANOPARTICLES MARKET, 2023                171

FIGURE 44            FINANCIAL METRICS OF KEY COMPANIES IN GOLD

NANOPARTICLES MARKET, 2023                172

FIGURE 45            GOLD NANOPARTICLES MARKET: BRAND/PRODUCT COMPARISON             173

FIGURE 46            GOLD NANOPARTICLES MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2023     174

FIGURE 47            GOLD NANOPARTICLES MARKET: COMPANY FOOTPRINT       175

FIGURE 48            GOLD NANOPARTICLES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 181

FIGURE 49            JOHNSON MATTHEY: COMPANY SNAPSHOT                 200

FIGURE 50            TANAKA PRECIOUS METAL GROUP CO.: COMPANY SNAPSHOT   202

FIGURE 51            SIGMA ALDRICH: COMPANY SNAPSHOT                 206

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
• 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
• オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
• 建設重機市場 – 2030年までの世界予測 2025-04-03
• 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02

MarketsandMarkets  出版レポート一覧